文献速递肾血管病与高血压慢性肾脏病急性肾损伤

细胞色素P450花生四烯酸代谢物在肾脏病学中的作用

Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.
PubMed 文献 · J Am Soc Nephrol · 2017-07-12

本文综述了细胞色素P450酶代谢花生四烯酸产生的20-羟基二十碳四烯酸(20-HETE)和环氧二十碳三烯酸(EETs)在肾脏生理与疾病中的作用。20-HETE相关基因变异与人类高血压相关,EETs具有舒张血管和抗炎特性,可能抑制高血压和慢性肾脏病(CKD)进展。综述还总结了这些类花生酸在常染色体显性多囊肾病、急性肾损伤(AKI)和CKD发病中的新兴证据。

要点

  • 20-HETE相关基因变异与人类高血压相关,但EETs基因变异的证据较弱。
  • EETs是血管舒张剂,具有抗炎特性,可对抗高血压和CKD的发展。
  • 20-HETE在肾缺血后升高,可能保护损伤,但在多囊肾病中可能促进囊肿形成。

核心结论

  • 细胞色素P450类花生酸在高血压、多囊肾病、AKI和CKD的发病机制中可能发挥作用。
  • 20-HETE相关基因变异与人类高血压相关,而EETs基因变异的证据尚不充分。

研究设计与样本

  • 综述,总结细胞色素P450花生四烯酸代谢物在肾脏病学中作用的新兴证据。

主要发现

  • 20-HETE具有血管收缩和促钠排泄双重作用,其机制仍有争议。
  • EETs是血管舒张剂,具有抗炎特性,可对抗高血压和CKD的发展。
  • 20-HETE水平在肾缺血后升高,可能保护损伤;在多囊肾病中升高,可能促进囊肿形成。

局限性

  • 20-HETE的作用机制尚存争议,尤其是其血管收缩与促钠排泄作用的平衡。
  • 支持EETs基因变异与人类疾病关联的证据不如20-HETE充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thirty-five years ago, a third pathway for the metabolism of arachidonic acid by cytochrome P450 enzymes emerged. Subsequent work revealed that 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids formed by these pathways have essential roles in the regulation of renal tubular and vascular function. Sequence variants in the genes that produce 20-hydroxyeicosatetraenoic acid are associated with hypertension in humans, whereas the evidence supporting a role for variants in the genes that alter levels of epoxyeicosatrienoic acids is less convincing. Studies in animal models suggest that changes in the production of cytochrome P450 eicosanoids alter BP. However, the mechanisms involved remain controversial, especially for 20-hydroxyeicosatetraenoic acid, which has both vasoconstrictive and natriuretic actions. Epoxyeicosatrienoic acids are vasodilators with anti-inflammatory properties that oppose the development of hypertension and CKD; 20-hydroxyeicosatetraenoic acid levels are elevated after renal ischemia and may protect against injury. Levels of this eicosanoid are also elevated in polycystic kidney disease and may contribute to cyst formation. Our review summarizes the emerging evidence that cytochrome P450 eicosanoids have a role in the pathogenesis of hypertension, polycystic kidney disease, AKI, and CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Fan F, Roman RJ. Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology. J Am Soc Nephrol. 2017. PMID: 28701518. doi:10.1681/ASN.2017030252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。